GERALD HEINTZ: Open Payments
NPI 1265521579 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$242 in 13 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $242
Food & beverage: $230Education: $12
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 9 | $138 |
| Supernus Pharmaceuticals, Inc. | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
Products named: FANAPT, Qelbree, REXULTI, Auvelity, TRINTELLIX.
Industry payments across LA — which companies pay providers there.
